As of 2025-12-16, the Relative Valuation of Evelo Biosciences Inc (EVLO) is (22.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of Evelo Biosciences Inc based on Relative Valuation is -22769918.3%.
The range of the Relative Valuation is (16.44) - (30.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 14.3x | 9.7x |
| Forward P/E multiples | 7.6x - 15.0x | 11.3x |
| Fair Price | (16.44) - (30.92) | (22.77) |
| Upside | -16437740.2% - -30923681.8% | -22769918.3% |
| Date | P/E |
| 2025-12-12 | -0.00 |
| 2025-12-03 | -0.00 |
| 2025-12-01 | -0.00 |
| 2025-11-26 | -0.00 |
| 2025-11-20 | -0.00 |
| 2025-11-10 | -0.00 |
| 2025-11-07 | -0.00 |
| 2025-11-05 | -0.00 |
| 2025-11-04 | -0.00 |
| 2025-11-03 | -0.00 |
| 2025-10-31 | -0.00 |
| 2025-10-29 | -0.00 |
| 2025-10-20 | -0.00 |
| 2025-10-14 | -0.00 |
| 2025-10-13 | -0.00 |
| 2025-10-08 | -0.00 |
| 2025-10-07 | -0.00 |
| 2025-10-06 | -0.00 |
| 2025-09-29 | -0.00 |
| 2025-09-26 | -0.00 |
| 2025-09-24 | -0.00 |
| 2025-09-18 | -0.00 |